Ghent University Academic Bibliography

Show Sort by

Your filters: cql: parent exact "RADIOTHERAPY AND ONCOLOGY"

Mark
Economic data for particle therapy : dealing with different needs in a heterogeneous landscape

Yolande Lievens (UGent) and Klaus Nagels

(2018) RADIOTHERAPY AND ONCOLOGY. 128(1). p.19-25
Mark
Adjuvant breast radiotherapy : how to trade-off cost and effectiveness?

Christel Monten (UGent) and Yolande Lievens (UGent)

(2018) RADIOTHERAPY AND ONCOLOGY. 126(1). p.132-138
Mark
- journalArticle
ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer

Carl Salembier, Geert Villeirs, Berardino De Bari, Peter Hoskin, Bradley R. Pieters, Marco Van Vulpen, Vincent Khoo, Ann Henry, Alberto Bossi, Gert De Meerleer, et al.

(2018) Radiotherapy and Oncology. 127(1). p.49-61
Mark
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

Ursula Nestle, Dirk De Ruysscher, Umberto Ricardi, Xavier Geets, Jose Belderbos, Christoph Poettgen, Rafal Dziadiuszko, Stephanie Peeters, Yolande Lievens (UGent) , Coen Hurkmans, et al.

(2018) RADIOTHERAPY AND ONCOLOGY. 127(1). p.1-5
Mark
- misc
Doing the right thing : quality in radiotherapy, a European perspective

A Vaandering, N Jornet, P Scalliet, M Coffey and Yolande Lievens (UGent)

(2018) RADIOTHERAPY AND ONCOLOGY. 127(2). p.161-163
Mark
- journalArticle
- A1
ESTRO ACROP : technology for precision small animal radiotherapy research : optimal use and challenges

Frank Verhaegen, Ludwig Dubois, Stefano Gianolini, Mark A. Hill, Christian P. Karger, Kirsten Lauber, Kevin M. Prise, David Sarrut, Daniela Thorwarth, Christian Vanhove (UGent) , et al.

(2018) RADIOTHERAPY AND ONCOLOGY.
Mark
Estimating the number of fractions by tumour site for European countries in 2012 and 2025 : an ESTRO-HERO analysis

Josep M Borras, Cai Grau, Julieta Corral, Karen Wong, Michael B Barton, Jacques Ferlay, Freddie Bray and Yolande Lievens (UGent)

(2018) RADIOTHERAPY AND ONCOLOGY. 126(2). p.198-204
Mark
- conference
- C3
Dosimetric aspects in the development of a crawl positioning device for prone breast radiotherapy

L Paelinck, Bert Boute (UGent) , Liv Veldeman (UGent) , Carlos De Wagter (UGent) , Bruno Speleers (UGent) , Annick Van Greveling (UGent) , Giselle Post (UGent) and Wilfried De Neve (UGent)

(2017) RADIOTHERAPY AND ONCOLOGY. 123(suppl. 1). p.S796-S796
Mark
- journalArticle
Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? : a randomized controlled trial

Leen Paelinck (UGent) , Akos Gulyban, Ferenc Lakosi, Tom Vercauteren (UGent) , Werner De Gersem (UGent) , Bruno Speleers (UGent) , Christel Monten (UGent) , THOMAS MULLIEZ, Patrick Berkovic, Annick Van Greveling (UGent) , et al.

(2017) RADIOTHERAPY AND ONCOLOGY. 122(1). p.30-36
Mark
Cost evaluation to optimise radiation therapy implementation in different income settings : a time-driven activity-based analysis

Jacob Van Dyk, Eduardo Zubizarreta and Yolande Lievens (UGent)

(2017) RADIOTHERAPY AND ONCOLOGY. 125(2). p.178-185

Academic Bibliography

Economic data for particle therapy : dealing with different needs in a heterogeneous landscape

Adjuvant breast radiotherapy : how to trade-off cost and effectiveness?

ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer

Doing the right thing : quality in radiotherapy, a European perspective

ESTRO ACROP : technology for precision small animal radiotherapy research : optimal use and challenges

Estimating the number of fractions by tumour site for European countries in 2012 and 2025 : an ESTRO-HERO analysis

Dosimetric aspects in the development of a crawl positioning device for prone breast radiotherapy

Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? : a randomized controlled trial

Cost evaluation to optimise radiation therapy implementation in different income settings : a time-driven activity-based analysis

Contents

Support

Contact